Chief Commercialization Officer-US @ (May 2019 - December 2020)
CEO and Chairman @ DHK Pharma Inc (July 2007 - March 2016)
Director - President and Publisher of Elsevier Oncology @ (October 2007 - May 2011)
VP of Commercial Operations @ Cytogen Corporation (July 2005 - June 2007)
Director of New Product Commercialization @ (January 2001 - July 2005)
Product Manager @ (April 1997 - December 2001)
Sales and Marketing @ (April 1986 - January 1997)
Dan Kim Education
Saint Joseph's University - Erivan K. Haub School of Business
MBA (Marketing)
2000-2003
The Wharton School
Management Development (Management Development)
1996-1996
Virginia Commonwealth University
BS (Psychology)
1979-1983
Dan Kim Skills
Regulatory Affairs
Sales
Technology Transfer
Managed Care
Drug Development
Program Management
Leadership
Pharmaceutical Sales
Marketing Strategy
CRO
Sales Management
Product Management
Life Sciences
Global Marketing
Product Development
Pharmaceutics
Infectious Diseases
Strategic Planning
Project Management
Marketing
Product Launch
Business Development
Clinical Development
Commercialization
Market Research
Oncology
Cardiology
Management
Healthcare
Medical Devices
Sales Effectiveness
Pharmaceutical Industry
Biotechnology
Training
Cross Functional Team Leadership
Strategy
Lifesciences
Clinical Trials
Start Ups
Dan Kim Summary
Dan Kim, based in Morris Plains, NJ, US, is currently a Chief Executive Officer at GENOPSY-US. Dan Kim brings experience from previous roles at SLBST Pharma Inc., Cancer Computer, DHK Pharma Inc and Elsevier. Dan Kim holds a 2000 - 2003 MBA in Marketing @ Saint Joseph's University - Erivan K. Haub School of Business. With a robust skill set that includes Regulatory Affairs, Sales, Technology Transfer, Managed Care, Drug Development and more. Dan Kim has 1 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Dan Kim?
Find contact details for 700 million professionals.